This week, for the first time in more than a decade, the Canadian Trademarks Office announced that it will grant requests for expedited examination of trademark applications. However, expedited examination will be limited to applications where the goods or services are for the prevention or treatment of COVID-19.
This is a notable change in practice, since there is currently a significant backlog facing trademark applications in Canada, with delays in examination of about 2 years from filing.
Background to delays at the Canadian Trademarks Office
Many years ago, perhaps around 15 or so, the Canadian Trademarks Office was very backlogged, with long delays between the filing of trademark applications and examination of the applications.
At that time, requests for expedited examination were granted in certain cases.
However, because the criteria for granting expedited prosecution were somewhat vague, the expedited examination process was abused by some applicants. As well, examination times subsequently improved considerably. Accordingly, the Trademarks Office stopped granting expedited prosecution requests.
Unfortunately, for several reasons, including changes to Canadian trademark law in 2019 exacerbated by pandemic-related challenges, delays at the Trademarks Office have again increased significantly. Currently, the delay from filing to examination is about 2 years.
Expedited examination of trademark applications related to COVID-19
As of December 14, 2020, for the first time in more than a decade, the Canadian Trademarks Office will grant requests for expedited examination. However, expedited examination will only be permitted for a very limited range of situations, all of which must have a connection to COVID-19.
In particular, to qualify for expedited examination, the following requirements must be met:
- The request must be filed in the form of an affidavit or statutory declaration; and
- The goods or services in the application must be for the prevention, diagnosis or treatment of Covid-19; and
- One of the following three criteria must be met:
- A Canadian court action must be underway with respect to the mark in issue in association with the goods or services listed in the trademark application; or
- The applicant must be in the process of combating counterfeit products at the Canadian border with respect to the mark in association with the goods or services listed in the application; or
- Approval for use of the goods or services listed in the application must have been submitted to or obtained from Health Canada.
For the moment at least, requests for expedited examination for any other reason will be rejected.
If a request for expedited examination is granted and if the applicant later misses any deadline or seeks an extension of time, the Trademarks Office may cease further expedited examination from that point.
The Trademarks Office has issued a Practice Notice which sets out the requirements in greater detail.
For further information please contact a member of our Trademarks & Brand Protection team.
The preceding is intended as a timely update on Canadian intellectual property and technology law. The content is informational only and does not constitute legal or professional advice. To obtain such advice, please communicate with our offices directly.
Related Publications & Articles
-
Avoiding a finding of ambiguity and ensuring patent validity: the importance of a comprehensive disclosure and defining coined terms
On June 7, 2024, the Federal Court issued its Judgment and Reasons in Tekna Plasma Systems Inc v AP&C Advanced Powders & Coatings Inc (2024 FC 871), finding all claims of the Defendant’s Canad...Read More -
Upcoming changes to Canada’s trademarks regime: what brand owners and their counsel need to know
On April 1, 2025, long-awaited amendments to Canada’s Trademarks Act and Trademarks Regulations will come into force. The purpose of the amendments is to discourage abuse of Canada’s trademarks regime...Read More -
When patents expire but royalty payments don’t: contrasting U.S. and Canadian approaches to patent licensing
How does the expiration of the patents in one jurisdiction impact global royalty payments? This question was addressed by the United States Court of Appeal’s Ninth Circuit in C.R. Bard Inc v Atrium Me...Read More